Picture of Werewolf Therapeutics logo

HOWL Werewolf Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Werewolf Therapeutics Reports Fourth Quarter 2021 And Full Year 2021 Financial Results

March 24 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS REPORTS FOURTH QUARTER 2021 AND FULL
YEAR
2021 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
    * WEREWOLF THERAPEUTICS - EXPECTS EXISTING CASH, EQUIVALENTS
TO
ENABLE FUNDING OF OPERATING EXPENSES AND CAPEX NEEDS THROUGH AT
LEAST Q2 OF 2023
    * QTRLY LOSS PER SHARE $0.66
    * Q4 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX86v4lJ 
Further company coverage:  HOWL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Werewolf Therapeutics

See all news